Hu et al., 2022 - Google Patents
Hydrophilic phytosterol derivatives: A short review on structural modifications, cholesterol-lowering activity and safetyHu et al., 2022
View HTML- Document ID
- 309495805012788492
- Author
- Hu Y
- Ma C
- Chen X
- Bai G
- Guo S
- Publication year
- Publication venue
- Grain & Oil Science and Technology
External Links
Snippet
Phytosterols have received extensive attention owing to their excellent cholesterol-lowering activity and the role in cardiovascular diseases prevention. However, poor solubility in both oil and water limited the application of free phytosterols in the food industry. Chemical or …
- 230000000694 effects 0 title abstract description 54
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hu et al. | Hydrophilic phytosterol derivatives: A short review on structural modifications, cholesterol-lowering activity and safety | |
| Shahzad et al. | Phytosterols as a natural anticancer agent: Current status and future perspective | |
| Bae et al. | Effect of enzymatic hydrolysis on cholesterol-lowering activity of oat β-glucan | |
| WO2001032029A2 (en) | Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein | |
| Yu et al. | Beneficial health properties of psyllium and approaches to improve its functionalities | |
| WO2011077800A1 (en) | Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages | |
| CN105658216A (en) | Monoacylglycerols and fat-soluble nutrients for use in the treatment of maldigestion | |
| He et al. | Role of plant stanol derivatives in the modulation of cholesterol metabolism and liver gene expression in mice | |
| US20030203854A1 (en) | Composition for effecting serum cholesterol levels | |
| WO2005046580A2 (en) | Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism | |
| Carr et al. | Cholesterol-lowering phytosterols: factors affecting their use and efficacy | |
| KR101323513B1 (en) | Mixture of Phytosterol Ester(s) and 1,3-Diglyceride(s) for Use in the Treatment of Medical Conditions | |
| US20060039932A1 (en) | Application of phytosteroids (and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers | |
| Zhou et al. | Sterols and fat-soluble vitamins | |
| Wang et al. | Investigation into the bioavailability of synthesized phytosterol esters in vitro and in vivo using Caco-2 cell model and Wistar rats | |
| WO2001066560A2 (en) | Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders | |
| WO2005110400A1 (en) | Lipase inhibitor, cholesterol esterase inhibtor, neutral fat absorption inhibitor, cholesterol absorption inhibitor and cholesterol ester absorption inhibitor | |
| ES2398847T3 (en) | Composition comprising one or more phytosterols and / or phytostanols and glucomannan and uses of the composition to treat lipid disorders in individuals with and without type II diabetes | |
| CN101791079A (en) | Capsule for reducing weight and beautifying features | |
| RU2419438C2 (en) | Medication for inhibition of visceral fatty tissue accumulation | |
| US7147859B2 (en) | Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers | |
| US20070141123A1 (en) | Emulsions comprising non-esterified phytosterols in the aqueous phase | |
| KR20050084572A (en) | Derivatives comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease | |
| AU2003218547B2 (en) | A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus | |
| CN103637212B (en) | Tube feeding clinical nourishment with blood fat reducing effect and preparation method thereof |